Elon Musk and The New York Times: A Public Feud Over Drug Use Claims

Elon Musk, the CEO of Tesla, has been in a heated argument with The New York Times over a report about his drug use. The newspaper claimed that Musk's drug use was more serious than people knew, especially during the 2024 presidential campaign. They said he used strong drugs like ketamine, Ecstasy, and psychedelic mushrooms. They also mentioned he carried a daily pill box with about 20 pills, including ones that looked like Adderall. Musk did not like this report. He shared his own drug test results on his X account, saying he was clean. The New York Times responded by saying Musk was just upset because he didn't like their story. They said their report was well-researched and they stood by it. This argument started when the newspaper published their report in May. They talked to many people who knew Musk and saw private messages and photos. Musk called the report a lie and said he hadn't used ketamine in years. The newspaper said they gave Musk a chance to respond before publishing, but he didn't. Musk even challenged the newspaper and another publication, the Wall Street Journal, to take drug tests and share the results. He said they wouldn't do it because they were guilty. The newspaper didn't respond to this challenge. This back-and-forth has been going on for a while. It's not clear when or if it will end. Both sides seem to be standing their ground.